Back

15 July 2025

BSG Gut Highlights July 2025

BSG-Gut-Highlights.png


Colon

Early detection of colorectal cancer using aberrant circulating cell- free mitochondrial DNA fragmentomics

Wang S, Peng F, Dang M, et al. Early detection of colorectal cancer using aberrant circulating cell- free mitochondrial DNA fragmentomics. Gut 2025; 74: 961–970. doi:10.1136/gutjnl-2024-333533.

Read it here.


Coeliac Disease 

Serological screening for coeliac disease in an adult general population: the HUNT study

Andersen I, Lukina P, Dyrli O, et al. Serological screening for coeliac disease in an adult general population: the HUNT study. Gut 2025; 74: 918-925. doi: 10.1136/gutjnl-2024-333886.

Read it here.


Inflammatory Bowel Disease 

Stem Cell Transplantation for Refractory Crohn’s: Outcomes and Immune Mechanisms

Guisado D, Talware S, Wang X, et al. Reparative immunological consequences of stem cell transplantation as a cellular therapy for refractory Crohn’s disease. Gut 2025; 74: 894-905. doi: 10.1136/gutjnl-2024-333558.

Read it here.


Endoscopy 

Carbon footprinting and environmental impact of gastrointestinal endoscopy procedures at a tertiary care institution

Rughwani H, Kalapala R, Katrevula A, et al. Carbon footprinting and environmental impact of gastrointestinal endoscopy procedures at a tertiary care institution: a prospective multi-dimensional assessment. Gut 2025; 74: 926-934. doi: 10.1136/gutjnl-2024-332471. 

Read it here.


Hepatology 

Multiomics analysis of immune correlatives in hepatocellular carcinoma patients treated with tremelimumab plus durvalumab

Myojin Y, Babaei S, Trehan R, et al. Multiomics analysis of immune correlatives in hepatocellular carcinoma patients treated with tremelimumab plus durvalumab. Gut 2025; 74(6): 983-995. doi: 10.1136/gutjnl-2024-334026.

Read it here.


Pancreas 

Risk factors for pancreatic cancer in individuals with intraductal papillary mucinous neoplasms and no high-risk stigmata during up to 5 years of surveillance

Hamada T, Oyama H, Nevo D, et al. Risk factors for pancreatic cancer in individuals with intraductal papillary mucinous neoplasms and no high-risk stigmata during up to 5 years of surveillance: a prospective longitudinal cohort study. Gut 2025; 74(6): 971-982. doi: 10.1136/gutjnl-2024-333259.

Read it here.

Reviewers

  • Dr Catherine Hsu, Hepatology Registrar, King’s College Hospital NHS Foundation Trust, London, UK
  • Dr Kelly Chatten, Bolton NHS Foundation Trust, Bolton, UK
  • Dr Khurum Hakeem, Gastroenterology Registrar, University Hospital of North Durham, Durham, UK
  • Dr Abisoye Akintimehin, Gastroenterology Registrar London North West University Healthcare NHS Trust, London, UK
  • Dr James Sun, Pre-doctoral Clinical Research Excellence Fellow, Francis Crick Institute and King’s College London, London, UK
  • Dr Sam Withington, Gastroenterology Registrar, North West London, London, UK

BSG Gut Highlights is edited by Dr Philip J Smith, Honorary Consultant Luminal Gastroenterologist, Royal Liverpool Hospital, Liverpool University Hospitals NHS Foundation Trust, Mount Vernon, Liverpool, UK. Dr Smith is the Digital and Education Editor of Gut, Editor in chief of Frontline Gastroenterology and Associate Editor of BMJ Open Gastroenterology.

Funding: The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

Competing interests: None declared.

Provenance and peer review: Not commissioned; internally peer reviewed.

References